A revolution in weight loss treatment may force a reckoning for food and beverage companies | Who gets to decide who receives experimental medical treatments? | Many women struggle to breastfeed. Scientists are starting to ask why.

View online | Unsubscribe (one-click). For inquiries/unsubscribe issues, Contact Us

You Might Like � � � You Might Like � � � � � � � � � Don't like ads? Go ad-free with TradeBriefs Premium A revolution in weight loss treatment may force a reckoning for food and beverage companies - CNBC    If you have heard that new weight loss medications mean you can eat all the junk food you want and still lose weight — you've heard wrong. Still, it's undeniable that a huge shift is underway in how obesity and overweight is being treated by doctors due to a new class of drugs known as GLP-1 agonists. The drugs are more successful in achieving weight loss and appear to have fewer side effects than previous generations of obesity treatments. Their quick adoption is expected to have far-reaching consequences in many economic sectors. One such prediction came Monday from Morgan Stanley analysts who forecasted a 1.3% drop in calorie consumption in the U.S. by 2035. Continued here Who gets to decide who receives experimental medical treatments? - MIT Technology Review    For many patients, pushing for access to unproven treatments is their best chance of survival. And that’s worth the risk. Max was only a toddler when his parents noticed there was “something different” about the way he moved. He was slower than other kids his age, and he struggled to jump. He couldn’t run.  Blood tests suggested he might have a genetic disease— one that affected a key muscle protein. Max’s dad, Tao Wang, a researcher for a climate philanthropy organization, says he and his wife were initially in denial. It took them a few months to take Max for the genetic test that confirmed their fears: he had Duchenne muscular dystrophy. Continued here You Might Like � � � � � � � � � Many women struggle to breastfeed. Scientists are starting to ask why. - National Geographic (Premium)    We know more about cow’s milk than human milk. But new research about the makeup of breast milk and the factors influencing its production could change the lives of millions. Even in her groggy, post-sedation haze, Chandra Burnside was adamant about breastfeeding her firstborn son. It was May 2010, and the then 29-year-old lobbyist had just given birth in an emergency caesarean section in a Virginia hospital. Upset that the delivery hadn’t gone as planned, Burnside was determined to get breastfeeding right. After all, decades of research have shown that breast milk confers vital nutritional and health benefits to babies, including protection from illnesses like diabetes and from sudden infant death syndrome. But that didn’t go according to plan either. Burnside both nursed and then pumped her breast milk around the clock to keep her supply flowing, just as she had learned in the 45-minute class she had taken while pregnant. But after a couple weeks, her son still wasn’t gaining weight. The pediatrician urged her to feed him more; she was advised to supplement with formula if she couldn’t produce enough breast milk. But Burnside refused to give up on breastfeeding exclusively. Continued here

You are receiving this mailer as a TradeBriefs subscriber. We fight fake/biased news through human curation & independent editorials. Your support of ads like these makes it possible. Alternatively, get TradeBriefs Premium (ad-free) for only $2/month If you still wish to unsubscribe, you can unsubscribe from all our emails here Our address is 309 Town Center 1, Andheri Kurla Road, Andheri East, Mumbai 400059 - 437931932